DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
The FY26 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award funds product-driven ALS therapeutic research from preclinical validation through FDA IND-enabling studies. Projects must start with a lead compound and show proof-of-concept efficacy in at least one appropriate ALS preclinical model (whole-animal and/or cellular). A key focus is mechanism-specific, p…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Biomedical Research Projects
Motor Neurone Disease Association
-
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
National Institutes of Health
-
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers